chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized 11/30/2021; COVID-19 positive 11/30/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: Doctor Primary Care Provider at Discharge: Doctor Admission Date: 11/30/2021 Discharge Date: 12/1/2021 PRESENTING PROBLEM: Acute renal failure superimposed on chronic kidney disease, unspecified CKD stage, unspecified acute renal failure type  Pneumonia due to COVID-19 virus  COVID-19   HOSPITAL COURSE: Patient is a 77 year old male with a history of CVA causing left hemiparesis, MI, DM, MI, CAD, CHF, and renal failure who presented with 7-10 days of cough, shortness of breath, and fatigue.  He lives at healthcare facility. His vital signs were stable though while in ER required 3 liters of supplemental oxygen to maintain sats above 90%.  His covid test returned positive, creatinine 5.27, BNP 16,324, K-3.3, Mg 1.2, Procal 1.07, WBC - 12.20, and d-dimer 4,990. CXR showed bilateral patchy airspace disease greatest at the left lung base.  The patient expressed that he is not agreeable to dialysis or lasix administration. His desire is to be treated for infections, but to otherwise be made comfortable; he is open to consulting with Hospice.  He was given dexamethasone, azithromycin, ceftriaxone, magnesium, and potassium while in ER.  He was admitted observation to the hospitalist service for covid-19 pneumonia for further treatment and coordination with care management for discharge planning.   Patient met with care in from hospice today.  His son is a truck driver and was only unable to make it in today.  Healthcare facility agreed to accept patient back on comfort care.  Plan for meeting with  Hospice Thursday AM at 10:30 when patient's son can be present to sign on with. A prescription was sent in for Ceftin and Azithromycin for treatment of pneumonia. Prescription for morphine and robinal included with patient transfer papers. No further needs at this time, he was discharged in stable condition to healthcare facility via EMS.
Cellulitis - L Arm Temp. - 101.8 redness, swelling, tender which radiated to L axillary area, on 11-01-08 went to medical center.  Received IV antibiotic. Took BACTRIM  DS BID for 10 days
Patient stated that she felt unwell,  was given a bottle of water and took vital signs.  she was given another bottle of water and she stated that she had a large cup of coffee this morning and did not take her BP meds for the day.  At 11:10 took another set of vitals and took her down to ED and handed her over of staff for further evaluation.
side effects in my arm around the injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 41-years-old male patient received BNT162B2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date was not reported) via an unspecified route of administration on 08May2021 as second dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced still having side effects in his arm around the injection site. The outcome of the event was not recovered.
Elevated blood pressure, increased heart rate, slurred speech, unsteady on feet, clammy skin. Rested 15 minutes while monitored. Repeated vital signs. Blood pressure decreased, speech clear. Recently started taking medications for elevated blood pressure. Going home with spouse per her request after resting quietly for 1 hour. Encouraged to follow up with her physician or seek emergency medical care if symptoms return or worsen.
01/17/2021, 8:00 am: EXTREME weakness, fatigue, unable to come to standing, severe pain right arm, extreme confusion and hallucinations. Have supportive care at home. By 01/18/2021, finally able to stand with assistance at 1:00 pm, still residual confusion.
two - three weeks after shot, full flu symptoms. I had not been sick but 1 day in 2002 and not for years before that. Since shot, chest feels flu-ish, coughing a lot, headaches, diaharea, etc. Have not had a good day in 6 mos.
Several hours after the injection and I had a headache which has lasted three full days. 48 hours after injection I became very achy and ran a fever of 100.4. My stomach is sensitive and my head is clogged up. I have a sore throat. It?s been about 72 hours after the injection and I?m still feeling sick from it.
Thyroid storm diagnosed as Graves Disease treated via nuclear ablilation in Dec 2003... Initial symptoms: muscle weakness, confusion, heat intolerance, tremors, heart palpitations, bulging eyes, extreme weight loss (+50Lbs).
CHILD WAS GIVEN ADULT DOSE HEP B INSTEAD OF CHILD DOSE HEP B. UPON RECEIVING VACCINE, CHILD EXPERIENCED JERKY, SHAKY MOVEMENT FOR 5 SEC. CHILD WAS PALE AND DISORIENTED. CLIENT WAS SAFELY LAID ON A COT UNTIL REGAIN CONCIOUSNESS. ABLE TO VERBALIZE TIME, DATE, PLACE, AND SELF. 911 WAS CALLED AND ARRIVED TO TRANSPORT CHILD TO HOSPITAL.
in a 24 hour period, patient reported a red, inflamed and warm site of injection.  He was advised that taking ibuprofen would help with the redness and inflammation.  Reported on 10/6/19 that his arm was still red and irritated and irritation had spread over a 4' band surrounding the injection site over the last 7 days.  Advised that he be seen by a provider at this time, but the patient has no PCP
After receiving the vaccine every muscle in my body would ache at about 12oclock at night. I had a sore arm that lasted for awhile. I could hardly move. I woke up about 6AM, and I had a hard time getting out of bed. I cant take a lot of medication, but I did take some Tylenol that helped, but I still ached till noon. I had a previous appointment for something else. I didn't think I would be safe driving to get to my appointment, but I did. I went by myself and by noon after that I was feeling good.
no known adverse side effects; an improperly stored dose of GARDASIL 9 was administered to a patient; This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. On 10-AUG-2022, the patient was vaccinated with an improperly stored 0.5 mL dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot # U034200 exp date 21-OCT-2023) intramuscularly. The temperature of excursion was 49.4 F for a time frame of 72 hours. There was a previous temperature excursion of 34.5 F for 7 hours on 03-MAY-2022. The patient had no known side effects.
Severe soreness at site of injection, vertigo, nausea, fever, chills, lethargy.
Psoriasis aggravated/increase in psoriasis/ scales and cracks; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis aggravated/increase in psoriasis/ scales and cracks) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    There was no reported medical history.    On 25-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced PSORIASIS (Psoriasis aggravated/increase in psoriasis/ scales and cracks). At the time of the report, PSORIASIS (Psoriasis aggravated/increase in psoriasis/ scales and cracks) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medication details were provided. No treatment medication details were provided.   Patient reported an increase in psoriasis following Moderna Covid vaccine.   The reporter's causality for the event of psoriasis was not provided with SKYRIZI (RISANKIZUMAB).  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
On day 1 (day I was vaccinated) I experienced severe pain in my arm where I was injected with the vaccine 3 hours after receiving it. I couldn't use my arm for the rest of the day and had to take Tylenol to help with swelling and pain. Pain was dull and throbbing. The next morning I woke up to body chills, a low grade fever, muscle aches, vomiting, exhaustion/fatigue, coughing, and diarrhea. The injection site was still very tender, sore, and swollen with limited mobility. All symptoms subsided within two days other than fatigue and a sore arm. On day 3 I developed a cough that lasted 4-5 days. Other than a cough, I had no other symptoms after that. My arm was better with no pain and easy to use. Then on day 8 my arm started to swell again and I developed a distinct rash at the injection site. The skin around the area was hot to touch and very hard and tender. I took ibuprofen and rubbed out the arm to help. I contacted my provider and she examined the arm, concerned I was having a reaction and possibly developing cellulitis. On day 9 the rash spread to the whole upper arm and shoulder were hot to touch/feverish, painful, hard, and still swollen. The swelling has continued to move up my arm. I am seeking medical attention today on 1/7/21 for treatment of possible cellulitis.
Received phone call from patient's wife who stated that the evening of the 16th the patient started to have chills, nausea, vomiting, and difficulty sleeping. Patient's wife reported that patient had low body temperature (around 96 degrees). She reported that the patient continued to have these symptoms into the afternoon of the 17th as well. She reported that the patient tested negative for Covid. Shortly after our phone call I contacted the patient back (around 6 PM) and his wife informed me that the symptoms were starting to abate and the patient was feeling much better.
adult female who gets migraines every other day; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), outcome "unknown", described as "adult female who gets migraines every other day".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccinator administered vaccine to patient, however as she injected vaccine, the needle "popped" apart and disconnected from the syringe, causing the vaccine to splash all over the vaccinator's glove, and down patient's arm.  It was estimated that the patient received less than half of the vaccine.  Consulted Pharmacy team and utilized CDC COVID-19 Administration Errors and Deviations Table to determine a repeat dose needed to be administered.  Patient and patient's mother were informed of all details and decisions, and were in agreement of recommended actions before administration of repeat dose.  Patient tolerated well.
Bell?s palsy - left sided face paralysis  TX; Val acyclovir & prednisone  for 1 week Hope to recover in the coming months.
This case was reported by a consumer via call center representative and described the occurrence of allergy to vaccine in a 14-year-old female patient who received Flu Seasonal TIV Dresden. Previously administered products included ADVAIR (refer case US2016157860), PROAIR HFA (refer case US2016157860), ZANTAC (refer case US2016157860) and Steroids (patient's weight may have been from the use of steroids over time). Concurrent medical conditions included contact dermatitis (Sensitive skin, due to allergies, there are very few products that can be used since birth), allergic reaction to antibiotics (allergy to antibiotics cause red marks on the skin within 30 min.) and latex allergy (allergy to antibiotics cause red marks on the skin within 30 min.) On an unknown date, the patient received Seasonal Influenza vaccine at an unknown dose. On an unknown date, less than an hour after receiving Seasonal Influenza vaccine, the patient experienced allergy to vaccine and erythema. On an unknown date, the outcome of the allergy to vaccine and erythema were unknown. It was unknown if the reporter considered the allergy to vaccine and erythema to be related to Seasonal Influenza vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient's family had a history of being allergic to many items. The patient was very sensitive to shampoo, body wash, and soap. Shampoos could make sores on the head, itching and if you scratch the head, it bleeds and causes scabs. The patient received Flu vaccine and within 30 minute after vaccination the patient experienced allergy to vaccine. It was reported that, GlaxoSmithKline was not previously contacted about any adverse event for this patient. This case had been linked with the US2016157860, reported for the same patient.
Received both vaccines and went home. About a hour later started feeling ill and developed a fever with shakes. Fever persisted overnight but started to resolve the next day. The patient still currently feels under the weather but states that they feel much better and that they are getting better.
Blood pressure feels really high; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 16Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history included COVID-19 virus in the past year (2020) from which her husband died last year (2020), receiving occupation therapy (OT) at home, and stroke (in the past). The patient's concomitant medications were not reported. The patient received her first Pfizer COVID-19 vaccine dose on 16Jan2021 and is scheduled to receive her next COVID-19 vaccine booster on 06Feb2021. The last time the patient had her COVID-19 virus antibody blood work was on 11Jan2021, and her COVID-19 virus antibodies were down to 1.9 from 8 (on an unspecified date). The patient's COVID-19 virus antibodies have been progressively going down since she was first being tested for them. The patient received a call today that her occupational therapist tested positive for the COVID-19 virus. Both her occupational therapist and she were wearing masks when working together. The patient received the call today because she was exposed to the occupational therapist. The patient asked if she can still take the COVID-19 vaccine booster that she is scheduled for on Saturday (06Feb2021). The patient really wanted to get the COVID-19 vaccine booster on 06Feb2021. The patient was going to be speaking with a trained healthcare professional when she is transferred to Pfizer medical information. Anyone the patient has spoken to about getting her second COVID-19 vaccine has not been willing to answer her questions. The patient's blood pressure feels really high now (02Feb2021), and she has had a stroke in the past. The outcome of the event was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
Had immediate hot flash with lots of sweating and fainted. Unconscious for 1 minute and woke up feeling better and more cooled. Used ice packs and wet cloth to cool down.  Took blood pressure and pulse - BP: 95/60  Pulse: 59; is on blood pressure meds and was told this was his normal by his wife.
Vaccine was administered too low on the deltoid muscle, resulting in large redness and pain at the injection site for 5+ days
Vaccine given 9/1/04. Mother noticed induration 9/2/04. Patient in for visit on 9/3/04 with doctor.
severe rashes, loss of cognitive function, swelling, excessive screaming, inability to remain attentive, increases irritability to baths, touch and sounds
TOOK ONLY TWO DOSE; This spontaneous case (PVX2019-747) was received from a pharmacist on 27-Mar-2019. It describes a male consumer who "took only two dose", while being on Vivotif for an unknown indication.   Case report: The consumer took two doses of Vivotif and did not take any further dose for a week.   Action taken with Vivotif was not applicable.   The clinical outcome of the event "took only two dose" was unknown.  Company's Comment: The causality of the event "took only two dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only two dose" was considered as not applicable.
I had two break through Covid infections after 2nd dose. I had a sore throat with the case in December 2021. Currently I have a massive headache and a cough with sneezing and really tired. I came home from work Saturday and was very sleeping. I first had a sore throat and then felt feverish and had a fever. I tested positive the next day.
No signs or symptoms reported. No other AE reported; temperature excursion that occurred on 3/AUG/2021 and 5/AUG/2021; temperature excursion that occurred on 3/AUG/2021 and 5/AUG/2021; This spontaneous report was received from a medical assistant referring to an unreported age and gender patient. The patient's pertinent medical history, drug reactions or allergies, and concomitant medications were not reported.    The medical assistant reported that a temperature excursion occurred on 03-AUG-2021 and 05-AUG-2021 involving hepatitis A vaccine, inactivated (VAQTA) lot number T037788, verified to be valid for prefilled syringe formulation, with expiration date 30-APR-2022. The vaccine underwent a temperature excursion of 35.4 and 35.8 degrees Fahrenheit (F) for a cumulative timeframe of 15 minutes (product storage error). There was not a previous temperature excursion.   The 1-time dose vaccine was administered to the patient on an unspecified subsequent date in 2021 for prophylaxis (route and anatomical location of vaccination were not reported).  No signs or symptoms nor other adverse events (AE) were reported (no adverse event).  This is one of two reports received from the same reporter. ; Sender's Comments:  US-009507513-2109USA002589:
Stroke; Heart Attack; loss of appetite; weak in the legs; felt achy; felt yucky; felt queasy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke) and MYOCARDIAL INFARCTION (Heart Attack) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PANTOPRAZOLE for an unknown indication.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced DECREASED APPETITE (loss of appetite), MUSCULAR WEAKNESS (weak in the legs), PAIN (felt achy), DISCOMFORT (felt yucky) and NAUSEA (felt queasy). On 12-May-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke) (seriousness criteria hospitalization, medically significant and life threatening) and MYOCARDIAL INFARCTION (Heart Attack) (seriousness criteria hospitalization, medically significant and life threatening). The patient was hospitalized on 12-May-2021 due to CEREBROVASCULAR ACCIDENT and MYOCARDIAL INFARCTION. At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke), MYOCARDIAL INFARCTION (Heart Attack), DECREASED APPETITE (loss of appetite), MUSCULAR WEAKNESS (weak in the legs), PAIN (felt achy), DISCOMFORT (felt yucky) and NAUSEA (felt queasy) outcome was unknown.            Treatment information was not provided. The reporter reported that the patient did not have any medical conditions to cause the events.   This case was linked to MOD-2021-132255 (Patient Link).; Sender's Comments: This case concerns a 92-year-old male with serious unexpected events of cerebrovascular accident and myocardial infarction, and nonserious unexpected decreased appetite, muscular weakness, pain, discomfort and nausea. Latency 1 day after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient states she began not feeling well 11/19/05 in AM. Patient got fever to 103 and became nauseous. Nausea lasted until 11/21/05 and patient vomited this AM 11/21/05. Patient states she was feeling well before vaccine.
that has a pink spot line under his armpit area and lymph node; he is in tremendous amount of pain; This is a spontaneous report from a contactable consumer (parent). A 14-years-old male patient received bnt162b2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown dose number single dose for covid-19 immunization. Medical history and concomitant medications were not reported. The reporter was wondering if he can get some advice here, about the covid vaccine. (Not further clarified whether pfizer vaccine or not hence not captured in tab) The patient had a pink spot line under his armpit area and lymph node, and he was in tremendous amount of pain. And should that be normal or that severe reaction for a reaction? The reporter stated his son was about 18 hour into his injection. He was sorry, He guess he was like 32 hours into it. Reporter was informed about the role of Pfizer Medical Information. So they were closed right now. Should they call emergency room or what then, he was not sure. Reporter was advised to call 911 or nearest physician in case of any emergency. The outcome of event was unknown.  Information on the Lot/Batch number has been requested.
Patient filled out her VAR and stated she has had no reaction to vaccines before. She states that she has a needle phobia. After receiving her vaccine, she felt dizzy and fainted twice. EMS was called and took over the situation. The patient was walked away at her own free will.
The patient had a syncopal episode in the waiting area after receiving an anthrax vaccine.  He was unconscious for several seconds, without recollection of events.  He reports no history of similar events associated with giving blood in the past.  He denies any pain. He did not hit his head. Taken to the emergency room to be evaluated.  Where he was seen to be in no acute distress, he did not appear uncomfortable.  Vital signs were normal.  Skin was diaphoretic.   Diagnosed by ER physician as having a vasovagal syncope likely secondary to needlestick.  Discharged with return precautions given to him.
Patient received an expired dose of Pfizer Covid-19 vaccine. It was out of the refrigerator at 1700 on 2/8/22 at 1700, expired at 2300, then administered 2/9/22 at 0915-0930. Patient so far does not c/o of any adverse symptoms other than expected pain at injection site.
Received ZOSTAVAX on 2/7/14. Diagnosed with shingles 5/5/14.
Onset of malaise approximately 4 hours after vaccination. Attended dialysis next day at 2 pm, but had to cut treatment short by an hour because of not feeling well. Loss consciousness while driving home from dialysis center and was involved in a car accident. The loss of consciousness was sudden. when I revived seconds later, vision was in black and white and was unable to determine the color of traffic light. Blood pressure improved over the next thirty minutes while I was providing report to police officer about the accident.